Gautret B, Schmitt H
Eur J Pharmacol. 1984 Jun 15;102(1):159-63. doi: 10.1016/0014-2999(84)90351-0.
The cardiovascular effects of ethylketocyclazocine were studied in rats anaesthetized with pentobarbital and artificially ventilated. Ethylketocyclazocine (1 mg X kg-1 i.v.) induced a fall in heart rate and blood pressure. The bradycardia and the hypotension were not altered by bilateral vagotomy and atropine, but were inhibited by naloxone and Mr 2266 BS. Ethylketocyclazocine always induced bradycardia in beta-adrenoreceptor-blocked and pithed animals. This bradycardia was prevented by Mr 2266 BS. These results would suggest that a direct peripheral action may occur at kappa-sites, located on the heart after intravenous injection of ethylketocyclazocine in the rat.
在戊巴比妥麻醉并人工通气的大鼠中研究了乙基酮环唑辛的心血管效应。乙基酮环唑辛(1毫克/千克静脉注射)可导致心率和血压下降。双侧迷走神经切断术和阿托品不会改变这种心动过缓和低血压,但纳洛酮和Mr 2266 BS可抑制它们。乙基酮环唑辛在β-肾上腺素能受体阻断和去脑动物中总是诱发心动过缓。这种心动过缓可被Mr 2266 BS预防。这些结果表明,静脉注射乙基酮环唑辛后,大鼠心脏上的κ位点可能会发生直接的外周作用。